Impax Asset Management Group
EW icon

Impax Asset Management Group’s Edwards Lifesciences EW Stock Holding History

Impax Asset Management Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.12M Buy
34,534
+1,503
+5% +$126K 0.02% 235
2026
Q1 		$2.65M Buy
33,031
+10,399
+46% +$857K 0.02% 235
2025
Q4 		$1.93M Hold
22,632
– – 0.01% 234
2025
Q3 		$1.76M Sell
22,632
-543
-2% -$42.4K 0.01% 225
2025
Q2 		$1.81M Buy
23,175
+5,106
+28% +$381K 0.01% 231
2025
Q1 		$1.31M Buy
18,069
+621
+4% +$44.4K 0.01% 240
2024
Q4 		$1.29M Buy
17,448
+4,484
+35% +$314K 0.01% 262
2024
Q3 		$855K Buy
12,964
+5,164
+66% +$375K ﹤0.01% 293
2024
Q2 		$720K Hold
7,800
– – ﹤0.01% 285
2024
Q1 		$745K Hold
7,800
– – ﹤0.01% 296
2023
Q4 		$595K Buy
+7,800
New +$543K ﹤0.01% 332

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Impax Asset Management Group's EW Position: Q2 2026 in Review

Impax Asset Management Group increased its Edwards Lifesciences (EW) stake by 4.6% in Q2 2026, buying an estimated $126K and bringing the position to 34,534 shares worth $3.12M. The position accounts for 0.02% of the portfolio, ranked #235.

Impax Asset Management Group first reported a position in EW in Q4 2023 and has held it in 11 quarters since. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Impax Asset Management Group held 34,534 shares of Edwards Lifesciences worth $3.12M as of Q2 2026.
  • Impax Asset Management Group bought 1,503 Edwards Lifesciences shares in Q2 2026, an estimated $126K.
  • Edwards Lifesciences made up 0.02% of Impax Asset Management Group's portfolio in Q2 2026, its #235 holding.
  • Impax Asset Management Group first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 11 quarters since.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Impax Asset Management Group's 13F filing for Q2 2026, filed 11 Aug 2026.